Loading stock data…
IOSP
$78.19+1.71 (+2.24%)
Pre-Market$81.05+2.86 (+3.66%)· Last close May 5
Innospec Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Innospec Inc. in the Basic Materials sector is trading at $78.19. The stock is currently 18% below its 52-week high of $95.55, remaining 0.7% above its 200-day moving average. Technical signals show neutral RSI of 66 and bullish MACD crossover, explaining why IOSP maintains its current momentum and trend strength. The Whystock Score of 65/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Overbought levels (RSI 66) — risk of consolidation or pullback
Long-term trend bullish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$78.19
Potential Upside
13.9%
Whystock Fair Value$89.09
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus3 analysts
Mean target$99.33+27.0%
Range$93.00 – $105.00
Fundamentals
Innospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company operates through three segments: Performance Chemicals, Fuel Specialties, and ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$1.87B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
16.05
Beta
Defensive asset. Lower volatility than the S&P 500.
0.88
Div Yield
Strong income play. Yield provides a meaningful total return floor.
232.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
1.46%
Volume
Today's trading volume
147,201
Recent News
This Fund Disclosed Selling $18 Million in Alphatec Last Quarter. The Stock Just Tanked 20% After Earnings
This medical technology firm provides spinal surgery solutions to U.S. hospitals and surgical centers through proprietary devices.
Western Standard Sells Entire Select Medical Position Ahead of $3.9 Billion Buyout
Select Medical Holdings delivers rehabilitation and occupational health services through a nationwide network of hospitals and clinics.
Analysts Estimate Innospec (IOSP) to Report a Decline in Earnings: What to Look Out for
Innospec (IOSP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will Innospec (IOSP) Beat Estimates Again in Its Next Earnings Report?
Innospec (IOSP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Undiscovered Gems US Market April 2026
The United States market has experienced a flat performance over the last week, yet it has seen an impressive 30% rise over the past year with earnings projected to grow by 16% annually. In this dynamic environment, identifying stocks that are poised for growth and remain under the radar can offer unique opportunities for investors seeking to capitalize on these favorable conditions.